Alzheimer’s disease represents a progressive neurological condition that relentlessly impairs memory and cognitive abilities, ultimately stripping away the capacity to perform even the …
What can a family do? Two years have passed since my dear, gentle mum left this world at the age of 85, taken …
The relationship between cognitive abilities in youth and dementia risk in older age has been explored in an NIA-funded study, recently published in …
In the United States, over six million elderly individuals grapple with dementia. Despite its prevalence, the early warning signs of cognitive decline frequently …
Frontotemporal dementia (FTD) arises from a cluster of brain disorders that systematically degrade the frontal and temporal lobes. As these brain regions deteriorate, …
As the golden years approach, the looming prospect of dementia can be troubling. You might find yourself pondering: Are there preventative measures available? …
The U.S. Food and Drug Administration has granted approval for the use of Kisunla (donanemab-azbt) injection, a new treatment for Alzheimer’s disease. This …
The Biden-Harris Administration Announces a $200 Million Investment to Bolster Geriatric Care for Older Adults, with an Emphasis on Alzheimer’s and Dementia In …
The vast majority of the human genome, a staggering 98%, is composed not of genes encoding proteins but of DNA that regulates gene …
A groundbreaking study from the National Institute on Aging (NIA) has identified a promising fluid biomarker with the potential to detect two neurodegenerative …
Mild cognitive impairment (MCI) manifests as a slight yet discernible decline in cognitive abilities, including memory and thinking, that exceeds typical levels of …
In a study spearheaded by the University of Pennsylvania, researchers engaged with family caregivers of severe dementia patients through comprehensive interviews. These discussions …